Gina Mauro

Clara Mae Cirk opens up about her journey and using social media as an outlet to educate others.

Completing chemotherapy was an emotional milestone, marked by excitement, gratitude, and even frustration, according to Clara Mae Cirk, a 30-year-old woman who was diagnosed with stage 4 lung cancer.

Despite finishing chemotherapy, she says that the ongoing nature of immunotherapy makes it difficult to identify as a “survivor” and reconcile life after treatment. To cope, social media became a therapeutic outlet, leading to her “Questions with Clara” series, which educates others, shares personal experiences, and amplifies voices of those less comfortable speaking publicly.

Circk opens up about her cancer journey and using social media as an outlet to educate others in an interview with CURE.

You can follow Clara and her journey on TikTok and Instagram @C_Cirks. On these platforms, she openly answers questions about her diagnosis and treatment, shares updates on her condition, and creates a safe space for others with cancer to have an honest dialogue about their disease.

CURE: Many patients describe a mix of emotions when they complete chemotherapy, especially when ringing the bell

. How did it feel to reach that milestone as someone with stage 4 disease

, and what emotions came with ringing the bell?

: I did six rounds of chemo, and they didn't have a bell, so I was pretty bummed about that. The nurses all signed a certificate for me with their names, which was nice. I took a picture with the certificate, and then I got a video of me when they de-accessed my port for the last time for chemo. I was just like, “Yay!” That was exciting and emotional for me, because I had been looking forward to that day for so long. I had just had a 10-day hospital stay prior to that, so I was just excited to get it done and over with. Then I ended up back in the hospital after my last round of chemo, which was also kind of a bummer.

For me, it's hard because that day should have felt like the end of treatment. But since [I have] stage 4 disease, I will be on immunotherapy indefinitely, likely for the rest of my life. That is kind of difficult for me to wrap my head around, because I still have to go back to my cancer center and get the infusion, and still have my port accessed every three weeks. That’s kind of hard to balance “Am I done with treatment?” or “Does this qualify as treatment still, with immunotherapy forever?”

The word ‘survivor’ doesn't really resonate with me, honestly. I have a hard time using that word because I probably will never feel that sense of survivorship, I guess. It's hard for me to see other survivors. Everyone gets their hair back and they look normal; they kind of go back to reality. I feel like I'll never get there. That is overwhelming to me and upsetting and just a lot of emotions to work through, knowing that I'll probably never get back to my old self or my normal.

So, it's just a lot to wrap my head around.

Your “Questions with Clara” series on social media have resonated with so many.

What inspired you to start sharing your cancer journey

I've always done this silly thing on my private Instagram story of talking to my followers and pretending I'm an influencer. I started doing it a long time ago and just kept it to my close friends list on Instagram. It was just a way for me to dump my feelings out, and it was very therapeutic for me just to sit on camera and talk about stuff.

When this all happened, I thought, "What better way to process everything than to just record myself and talk about stuff?" I got kind of tired of explaining everything to my friends and family, so it was just an educational way for me to say, “Hey, watch this video if you want to know what my treatment is right now, or what part of the process I'm in.” It was a much easier way to just send a link and explain things rather than retyping the same thing over and over. So, yeah, I think that's where it came from.

I also feel like I noticed a lot of people, once I was diagnosed, started connecting with me on social media. I noticed they were posting videos about their journey, and that really inspired me because I wanted to talk about my story and how that's different or the same or whatever. I saw all these people going to these conferences and stuff, and I want to do stuff like that, like public speaking engagements and different events and advocacy.

That’s what motivated me to start the series, too, because I want to get involved in stuff. I'm just finding that doing all that is more of my true purpose in life. I found it to be fulfilling to talk about my story and help others.

I want to be a voice for people who aren't as comfortable speaking up and talking. I know a lot of people are shy about sharing their experiences or what they've been through, especially when it involves uncomfortable topics that I sometimes cover in my questions. I know that not everybody feels great about talking about those things in a public space, so I don't mind doing it.

What have been some of the most meaningful moments of support that you have received from the community, online or offline, throughout your cancer treatment?

It always feels good when I get a comment like the one I got yesterday: "You were one of the first cancer creators I followed when I was diagnosed, and I've really enjoyed learning from you." That means a lot to me because the whole point is that if I can help just one person, it's worth it. So, it's impactful to me that somebody took the time to tell me that and express their appreciation.

I also think it's helpful when we, as cancer patients, share each other's Venmo or GoFundMe links and other resources. It helps get the word out there and supports a fellow patient.

Transcript has been edited for clarity and conciseness.

“Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty,” by Clara Cirks. CURE. Video; Aug. 6, 2025. https://www.curetoday.com/view/finishing-chemo-with-stage-4-lung-cancer-facing-hope-and-uncertainty

“Using Social Media to Amplify the Patient Voice and Advocacy,” by Clara Cirks. CURE. Video; Aug 8, 2025. https://www.curetoday.com/view/using-social-media-to-amplify-the-patient-voice-and-advocacy

For more news on cancer updates, research and education, 

don’t forget to subscribe to CURE®’s newsletters here.

Articles

Clara Mae Cirk, a stage 4 lung cancer patient, shares her emotional journey post-chemotherapy, highlighting the challenges of ongoing immunotherapy and the struggle to identify as a "survivor." She uses social media as a therapeutic outlet, creating the "Questions with Clara" series to educate and connect with others. This platform allows her to share personal experiences, provide support, and amplify voices of those less comfortable speaking publicly. Her efforts have fostered a supportive community, offering meaningful connections and resources for fellow cancer patients.

Clara Mae Cirk, a 30-year-old who was diagnosed with stage 4 lung cancer, opens up about her journey and using social media as an outlet to educate others. 

Patient With Stage 4 Lung Cancer Shares How She Uses Social Media 

The FDA has granted fast track designation to stenoparib for patients with advanced ovarian cancer: © stock.adobe.com.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to stenoparib, an investigational therapy for patients with advanced ovarian cancer, according to a release from Allarity Therapeutics.

This designation is meant to speed the development and review of new treatments that target serious conditions and fill an unmet medical need, the release states. It also provides opportunities for more frequent FDA interactions and can offer eligibility for accelerated approval, priority review, or rolling submission if requirements are met.

“We are very pleased that the FDA has granted Fast Track designation to stenoparib,” said Thomas Jensen, CEO of Allarity Therapeutics. “This recognition underscores the significant unmet need facing women with advanced ovarian cancer and reflects the potential of stenoparib to meaningfully improve treatment outcomes.”

Phase 2 Clinical Trial of Stenoparib Now Enrolling Patients

Allarity opened enrollment of a new phase 2 trial studying the treatment in patients with advanced, recurrent ovarian cancer who are either platinum-resistant or platinum-ineligible. The first patient entered the trial in June 2025, and several patients have already started therapy.

The study builds on prior phase 2 findings, which showed clinical benefit. Some participants have remained on treatment for more than 22 months, suggesting the potential for durable responses. The trial also incorporates Allarity’s DRP companion diagnostic, which is designed to help identify patients most likely to respond to therapy and guide treatment decisions.

How Stenoparib Targets Specific Pathways in Ovarian Cancer

Stenoparib is an oral small-molecule drug that works as a dual inhibitor of PARP1/2 and tankyrase 1/2. Both pathways are linked to cancer development. By targeting these pathways, stenoparib offers a unique therapeutic mechanism compared with existing PARP inhibitors, the news release states.

Moreover, the drug was originally developed by Eisai Co. Ltd. and was previously known as E7449 and 2X-121. Allarity holds exclusive global rights to further develop and commercialize the therapy.

DRP Companion Diagnostic Helps Match Patients to Treatment

The DRP technology uses messenger RNA expression profiles from patient tumor biopsies to generate a gene signature that predicts response to a drug. Patients with a higher DRP score are thought to have a greater likelihood of benefiting from treatment. This platform has been studied across multiple clinical trials and has demonstrated the ability to predict outcomes.

“By screening patients before treatment, and only treating those patients with a sufficiently high, drug-specific DRP score, the therapeutic benefit rate may be enhanced,” the news release explains. “The DRP platform has shown an ability to provide a statistically significant prediction of the clinical outcome from drug treatment in cancer patients across dozens of clinical studies.”

For stenoparib, DRP may allow clinicians to better select patients who will respond, potentially improving overall treatment success.

Understanding Ovarian Cancer Symptoms, Risk, and Progression

Ovarian cancer begins when abnormal cells in the ovary grow and divide uncontrollably, according to information from the Cancer Research UK website. These cells may spread into nearby tissues or travel to other areas of the body. The ovaries are part of the reproductive system, which includes the vulva, vagina, uterus, cervix, fallopian tubes, and ovaries. Each ovary produces eggs during the reproductive years.

Anyone born with ovaries and fallopian tubes may develop ovarian cancer, including women, transgender men, and non-binary individuals, the website continues. Risk increases with age, peaking between ages 75 and 79. Although the exact cause is unknown, several factors can influence an individual’s likelihood of developing the disease.

“Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer,” by Allarity Therapeutics, Inc. News release; Aug. 26, 2025.

“What is Ovarian Cancer?,” by Cancer Research UK. https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/what-is-ovarian-cancer

For more news on cancer updates, research and education, don’t forget to 

subscribe to CURE®’s newsletters here.

The FDA has granted fast track designation to stenoparib, an investigational therapy for advanced ovarian cancer, to expedite its development and review. This designation allows for more frequent FDA interactions and potential accelerated approval. Stenoparib, a dual inhibitor of PARP1/2 and tankyrase 1/2, is currently in a phase 2 trial for patients with platinum-resistant or ineligible ovarian cancer. The trial uses Allarity's DRP companion diagnostic to identify patients likely to respond. Ovarian cancer risk increases with age, and its exact cause remains unknown.

The FDA has granted fast track designation to stenoparib, an investigational therapy for patients with advanced ovarian cancer.

FDA Gives Fast Track Designation to Stenoparib in Advanced Ovarian Cancer 

Learn about diagnosis, explore your thyroid cancer treatment options and find practical advice for managing side effects and living well after treatment.

Your Thyroid Cancer Journey: From Diagnosis to Survivorship

Thyroid cancer is a type of cancer that begins in the thyroid gland, a butterfly-shaped gland located at the base of your neck. The thyroid gland is responsible for producing hormones that regulate your metabolism, heart rate, blood pressure and body temperature.

There are four main types of thyroid cancer:

 This is the most common type, accounting for about 80% of all cases. It tends to grow slowly and is highly treatable.

This is the second most common, making up about 10% to 15% of cases. It's also very treatable, especially when caught early.

This is a rare form that develops in the C cells of the thyroid. It can be associated with genetic syndromes.

: This is the most aggressive and rarest type of thyroid cancer. It's challenging to treat and often spreads quickly.

Diagnosing thyroid cancer typically involves a series of steps to confirm the presence of cancer and determine its type and stage.

 Your doctor will feel your neck for any lumps or nodules on the thyroid gland.

 This imaging test uses sound waves to create a detailed picture of your thyroid. It helps determine the size, shape and characteristics of any nodules.

 A small, thin needle is used to take a sample of cells from the thyroid nodule. These cells are then examined under a microscope by a pathologist to check for cancer.

 These tests measure the levels of thyroid hormones and other substances in your blood to check your thyroid function.

 If your doctor suspects medullary thyroid cancer, they may recommend genetic testing to check for a mutation in the RET gene, which can be linked to this type of cancer.

Thyroid cancer is often highly treatable, and the best course of action depends on the type, size and stage of the cancer, as well as your overall health.

 This is the most common treatment for thyroid cancer. The two main types of surgery are:

 Removal of only the lobe of the thyroid that contains the cancer.

 This treatment uses a pill or liquid containing radioactive iodine to destroy any remaining thyroid tissue or cancer cells after surgery. This is particularly effective for papillary and follicular thyroid cancer because these cells absorb iodine.

 After a thyroidectomy, you will need to take a synthetic thyroid hormone pill daily for the rest of your life to replace the hormones your thyroid gland used to produce. This also helps suppress the growth of any remaining cancer cells.

 This uses a machine to deliver high-energy radiation to the cancer cells. It's often used for advanced cases, such as anaplastic thyroid cancer.

 These treatments are usually reserved for more advanced cases, such as anaplastic or medullary thyroid cancer that has not responded to other treatments.

What Does Life Look Like with Thyroid Cancer?

Living with thyroid cancer is a journey that extends beyond the initial treatment. It involves ongoing physical and emotional management, as well as a focus on long-term health. The goal is not just to be cancer-free, but to live a full and healthy life.

Side Effect Management With Thyroid Cancer Treatment

Even after successful treatment, you may experience short-term or long-term side effects. Being proactive about managing them can significantly improve your quality of life.

 This is a lifelong necessity after a thyroidectomy. Your doctor will carefully monitor your hormone levels with blood tests. It's crucial to take your medication as prescribed. Side effects from hormone imbalance, whether it is too much or too little, can include:

High levels: Rapid heart rate, anxiety, weight loss or cramps.

Low levels: Fatigue, weight gain, dry skin or thinning hair.

If you experience these, discuss them with your doctor so they can adjust your dosage.

 This can cause temporary or, in some cases, permanent side effects.

Dry mouth and taste changes: RAI can affect your salivary glands. Sucking on sour candies (like lemon drops) can help stimulate saliva production and provide some relief. Staying hydrated is also very important.

Fatigue: It's common to feel tired for several weeks or even months after RAI therapy. Listen to your body and prioritize rest.

In an interview with Targeted Oncology®, a sister brand of CURE®, Dr. Noah S. Kalman, a radiation oncologist at Miami Cancer Institute at Baptist Health South Florida, 

discussed that quality-of-life management during and after thyroid cancer treatment

 may be challenging, especially because of RAI, which involves a temporary low-salt diet.

“That is probably the most difficult part about the treatment itself and having to follow that diet for a number of weeks,” Kalman said in the interview. “That’s what we get the most complaints about from patients, as it can be very disruptive.”

 After surgery, you may experience hoarseness or voice changes. This is usually temporary as the nerves near the thyroid gland heal, but for a small number of patients, it can be permanent. A voice therapist or speech pathologist can provide exercises to help. You may also feel a tightness or a pulling sensation around the incision, which can be managed with gentle massage and stretching exercises as advised by your healthcare team.

 Maintaining a healthy lifestyle is a cornerstone of recovery. Regular, moderate exercise can help combat fatigue and improve your mood. A balanced diet can help your body heal and maintain a healthy weight, which is important for your overall well-being.

“If patients do have some issues with treatment, whether it’s 

, some patients can have occasionally some swallowing issues after their thyroid surgery, [but] there are some resources available,” Kalman said. “There are speech therapies, there are medications to help with dry mouth — there are things we can do to help manage some of these patients’ symptoms going forward.”

A cancer diagnosis can take a significant emotional toll, and these feelings can persist long after treatment. It's important to acknowledge and address them.

 It's normal to feel a mix of relief, fear and anxiety. You may feel pressure to "return to normal," but give yourself time to adjust to your "new normal."

 Many patients experience anxiety, especially leading up to follow-up appointments and scans. This is often called "scanxiety." Talk to your healthcare team about these feelings. Knowing what to expect during your appointments and understanding your follow-up care plan can help reduce some of this stress.

 You are not alone in this journey. Connecting with other thyroid cancer survivors through support groups or online forums can provide a sense of community and help you feel understood. Your hospital or a cancer support organization can often provide resources.

 If you're struggling with persistent feelings of sadness, depression or anxiety, consider speaking with a therapist or a social worker. They can offer strategies and support to help you cope.

Thyroid Cancer Survivorship and Recurrence

Thyroid cancer generally has an excellent prognosis, and many patients are cured. However, it is essential to be aware of the concept of survivorship and the possibility of recurrence.

 "Cancer survivorship" begins at the time of diagnosis and continues throughout the rest of your life. It involves managing the physical and psychological effects of cancer and its treatment, as well as focusing on long-term health and well-being. Your oncologist will provide a survivorship care plan, which outlines your treatment history, potential late effects to watch for, and a schedule for your future follow-up care.

 While rare, thyroid cancer can recur, sometimes many years after the initial treatment. This is why long-term follow-up is so important.

Risk factors: The risk of recurrence depends on factors such as the type and stage of cancer at diagnosis, the size of the original tumor and whether it spread to nearby lymph nodes.

Signs to watch for: Be vigilant for any new lumps in your neck, a lingering cough, difficulty swallowing or voice changes. Regular follow-up appointments, which may include physical exams, blood tests (for a protein called thyroglobulin) and ultrasounds are designed to detect any signs of recurrence early.

Treatment for recurrence: If cancer does return, it is often found in the lymph nodes in the neck and can be effectively treated with a second surgery, and sometimes with radioactive iodine or other therapies.

Taking Control of Your Thyroid Cancer Journey

Thyroid cancer has a very high cure rate, especially for the most common types. By understanding your diagnosis and treatment options, you can actively participate in your care and make informed decisions with your medical team. Your journey is unique, and your healthcare providers are your partners in navigating this process. Don't hesitate to ask questions, seek second opinions, and advocate for your health.

This guide is designed to be a starting point. Your personal experience will be unique. By using this information as a foundation for your discussions, you can partner with your oncologist to make the best decisions for your health.

For more news on cancer updates, research and education,

CURE. "Managing Quality of Life After Iodine Treatment for Thyroid Cancer." 

https://www.curetoday.com/view/managing-quality-of-life-after-iodine-treatment-for-thyroid-cancer

Thyroid cancer originates in the thyroid gland, with four main types: papillary, follicular, medullary, and anaplastic, each varying in prevalence and aggressiveness. Diagnosis involves physical exams, ultrasounds, biopsies, blood tests, and genetic testing. Treatment options include surgery, radioactive iodine therapy, hormone therapy, radiation, and chemotherapy, depending on cancer type and stage. Post-treatment, managing side effects and maintaining emotional well-being are crucial. Survivorship involves ongoing monitoring for recurrence, with a focus on long-term health. Patients are encouraged to actively participate in their care and seek support.

Breast Cancer: What You Need to Know About Types, Staging and Genetics 

Breast cancer is a complex disease, but understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist. This guide provides an overview of the key topics in breast cancer care, from diagnosis to survivorship.

What Are the Different Types of Breast Cancer?

Breast cancers are classified by the cells they originate from. The two most common types are:

: This is the most prevalent type, starting in the milk ducts and then invading surrounding breast tissue.

: This type begins in the milk-producing lobules and spreads to surrounding tissues.

Other types of breast cancer are defined by the presence or absence of hormone and protein receptors:

Hormone receptor–positive (HR+) breast cancer

: the most common type, meaning the cancer grows in response to hormones. This includes estrogen receptor–positive (ER+) and progesterone receptor–positive (PR+) cancers, which often respond well to hormone-blocking therapies

: has higher-than-normal levels of the HER2 protein, which drives cancer growth and can be treated with targeted therapies

: does not have estrogen, progesterone, or HER2 receptors. It is often more aggressive and may require chemotherapy or newer targeted treatments

: a rare, fast-growing cancer that causes swelling, redness, and thickened skin of the breast

: affects the nipple and sometimes the areola, often presenting with redness, scaling, or irritation

: include medullary, mucinous, and tubular breast cancers, each with unique cellular features

Staging describes the extent of the cancer’s spread. It’s a crucial tool that helps doctors determine the best treatment plan and predict the prognosis. The staging system typically uses a scale of 0 to IV.

: Non-invasive cancer, such as ductal carcinoma insitu (DCIS).

: Small invasive tumor, contained within the breast.

I: Larger tumors or cancer that has spread to nearby lymph nodes.

: Metastatic breast cancer, meaning it has spread to distant parts of the body like the bones, liver, or lungs.

What Is the Role of Genetics, Such as BRCA1/2, in Breast Cancer?

Genetic factors play a significant role in some breast cancers. Mutations in the BRCA1 and BRCA2 genes are the most well-known. These genes normally help repair cell damage and prevent cancer development. A mutation in one of these genes significantly increases a person's risk of developing breast cancer and other cancers, such as ovarian cancer. Genetic testing can determine if you carry one of these mutations, which may influence your treatment and screening plan.

Breast Cancer Diagnosis: What Tests Are Used?

A definitive diagnosis of breast cancer is made through a biopsy, where a small tissue sample is taken and examined by a pathologist. Additional tests help classify the cancer, including:

: This test determines if the cancer cells have receptors for the hormones estrogen (ER) and progesterone (PR). Cancers that are ER-positive or PR-positive may be treated with hormone therapy.

: This test checks for the presence of the HER2 protein. Cancers that are HER2-positive tend to grow faster but can be treated with targeted therapies.

 This is a marker that indicates how fast the cancer cells are dividing.

For some patients with early-stage, ER-positive breast cancer, the Breast Cancer Index (BCI) is a genomic test that can help predict the likelihood of cancer recurrence after five years of hormonal therapy. This information can help you and your oncologist decide whether to continue hormone therapy beyond five years.

What Are the Available Breast Cancer Treatment Options?

Treatment plans are highly individualized and often involve a combination of therapies.

 This is often the first step to remove the tumor. Options include a lumpectomy, which removes only the tumor and a small amount of surrounding tissue, or a mastectomy, which removes the entire breast.

:This therapy uses high-energy rays to kill any remaining cancer cells in the breast or chest wall. It is often used after a lumpectomy.

: These powerful drugs are used to kill fast-growing cancer cells throughout the body. Chemotherapy may be given before surgery to shrink a tumor or after surgery to destroy any remaining cancer cells.

: This treatment is for ER-positive and PR-positive cancers. It works by blocking hormones from reaching cancer cells or by reducing hormone levels in the body to prevent cancer from growing.

: This treatment targets specific characteristics of cancer cells, such as the HER2 protein, with less harm to normal cells. It may include monoclonal antibodies, small molecule inhibitors, or antibody-drug conjugates, which deliver chemotherapy directly to cancer cells while sparing healthy tissue.

Dr. Erika Hamilton, a board-certified medical oncologist and director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute said in an interview with CURE

. “We not only have new agents, but we're quickly trying to move these agents up into earlier lines when they prove to be beneficial for our metastatic patients. It's a quickly emerging field. We treat breast cancer almost completely differently than we treated breast cancer a decade ago. This is really exciting, because it means our patients are doing better due to these advances.”

How to Manage Side Effects in Breast Cancer Treatment

Treatments can have various side effects, such as fatigue, nausea, or nerve pain. Discussing potential side effects with your care team and having a plan to manage them is crucial for maintaining your quality of life. Strategies may include medication adjustments, dietary changes, gentle exercise, or complementary therapies such as acupuncture, massage, or relaxation techniques. Staying hydrated, pacing daily activities, and getting adequate rest can also help manage fatigue. Communicating openly with your care team about new or worsening side effects ensures timely support and interventions.

Emotional Well-Being During and After Breast Cancer Treatment

A cancer diagnosis is emotionally challenging. Many patients benefit from support groups, therapy, or connecting with others who have gone through a similar experience. Mindfulness practices, journaling, meditation, or creative outlets like art or music can help manage stress and anxiety. It’s normal to experience a range of emotions, from fear and sadness to relief and gratitude. Patients may also find comfort in spiritual practices or connecting with community resources. Early recognition of emotional distress allows for timely support and can improve overall quality of life.

What Does Breast Cancer Survivorship Mean?

After active treatment ends, the focus shifts to survivorship. This includes regular follow-up appointments, monitoring for recurrence, and maintaining a healthy lifestyle. Survivorship also involves managing long-term side effects, addressing other health conditions, and restoring energy and strength. Patients may develop a survivorship care plan with their oncology team to guide ongoing health decisions. Survivorship can also include setting personal health goals, returning to social or professional activities, and maintaining emotional and mental well-being.

Even after successful treatment, there is a risk of recurrence. This can be a local recurrence, in the same area as the original tumor, or a distant recurrence, known as metastatic disease.

“We look at recurrence in several ways,” said Marla Sustin, a nurse practitioner at University Hospitals Seidman Cancer Center in Cleveland, 

“One approach uses prognostic tools, which examine clinical and pathological factors. Theother approach is predictive, often involving genomic testing. Predictive testing is more definitive—you run the test, it gives you an answer, and that guides the treatment path. Prognostic tools consider factors such as tumor size, grade, estrogen receptor status, and other characteristics. Using this information, we can classify patients as high risk, medium risk, or low risk.”

Staying in close contact with your oncologist is essential for long-term monitoring. Being aware of symptoms, following routine imaging and lab tests, and discussing risk-reduction strategies, including lifestyle changes, preventive medications, or clinical trials, can help detect recurrence early. Emotional support for coping with the possibility of recurrence is equally important.

Editor's note: This guide is designed to be a starting point. Your personal experience will be unique. By using this information as a foundation for your discussions, you can partner with your oncologist to make the best decisions for your health.

This article is for informational purposes only and is not a substitute for professional medical advice. Please contact your healthcare team with any questions or concerns.

For more news on cancer updates, research and education, 

Breast cancer encompasses various types, primarily classified by cell origin and receptor presence, such as IDC, ILC, HR+, HER2-positive, and triple-negative. Staging, from 0 to IV, guides treatment and prognosis. Genetic factors, notably BRCA1/2 mutations, significantly influence risk and management. Diagnosis involves biopsies and receptor status tests. Treatment options include surgery, radiation, chemotherapy, hormone, and targeted therapies. Managing side effects and emotional well-being is crucial. Survivorship focuses on monitoring, lifestyle, and recurrence risk. Prognostic and predictive tools aid in assessing recurrence risk and guiding treatment.

Breast cancer types, staging, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make informed care decisions. 

Gina Mauro

Patient With Stage 4 Lung Cancer Shares How She Uses Social Media

FDA Gives Fast Track Designation to Stenoparib in Advanced Ovarian Cancer

Your Thyroid Cancer Journey: From Diagnosis to Survivorship

Breast Cancer: What You Need to Know About Types, Staging and Genetics

Latest News